{"nct_id":"NCT02588092","title":"Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)","status":"TERMINATED","status_verified_date":"2020-02","start_date":"2016-02-01","start_date_type":"ACTUAL","primary_completion_date":"2018-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-29","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ADCT"]}